patient_id	feature_display	tested_subfeature	therapy_name	n_mut	n_wt	n_mut_tested	n_wt_tested	mut_ic50_median	mut_ic50_mean	mut_ic50_std	wt_ic50_median	wt_ic50_mean	wt_ic50_std	pvalue_mww	statistic
MEL-IPI_Pat38	BRAF p.V600E (Missense)	BRAF	Dabrafenib	264	1559	136	621	34.824	120.732	228.705	121.915	244.298	422.653	2.322e-12	58428.0
MEL-IPI_Pat38	BRAF p.V600E (Missense)	BRAF Somatic Variant	Dabrafenib	184	1639	98	659	19.092	80.76	176.13	120.697	243.118	416.712	7.627e-17	49130.0
MEL-IPI_Pat38	BRAF p.V600E (Missense)	BRAF Somatic Variant Missense	Dabrafenib	170	1653	89	668	19.04	82.289	184.013	119.74	240.726	414.446	6.330e-16	45390.0
MEL-IPI_Pat38	BRAF p.V600E (Missense)	BRAF Somatic Variant Missense p.V600E	Dabrafenib	101	1722	49	708	3.725	16.282	39.616	118.217	236.343	407.192	5.518e-23	31960.0
MEL-IPI_Pat38	BRAF p.V600E (Missense)	BRAF	Trametinib	264	1559	137	634	0.516	5.862	27.545	2.112	7.605	32.168	2.344e-09	57546.5
MEL-IPI_Pat38	BRAF p.V600E (Missense)	BRAF Somatic Variant	Trametinib	184	1639	99	672	0.364	4.887	30.17	2.152	7.65	31.568	9.083e-13	48043.5
MEL-IPI_Pat38	BRAF p.V600E (Missense)	BRAF Somatic Variant Missense	Trametinib	170	1653	90	681	0.271	5.095	31.639	2.147	7.586	31.365	2.900e-13	45139.0
MEL-IPI_Pat38	BRAF p.V600E (Missense)	BRAF Somatic Variant Missense p.V600E	Trametinib	101	1722	50	721	0.085	0.659	1.336	2.059	7.755	32.406	1.793e-14	29698.0
MEL-IPI_Pat38	EGFR p.L770F (Missense)	EGFR	Osimertinib	242	1581	138	614	4.126	9.455	14.253	5.746	11.61	24.66	0.006	48749.0
MEL-IPI_Pat38	EGFR p.L770F (Missense)	EGFR Somatic Variant	Osimertinib	120	1703	67	685	4.392	9.78	15.814	5.593	11.355	23.708	0.1	25741.0
MEL-IPI_Pat38	EGFR p.L770F (Missense)	EGFR Somatic Variant Missense	Osimertinib	103	1720	59	693	4.095	10.132	16.631	5.593	11.306	23.587	0.128	22883.0
MEL-IPI_Pat38	EGFR p.L770F (Missense)	EGFR Somatic Variant Missense p.L770F	Osimertinib	0	1823	0	752				5.522	11.214	23.111	nan	
MEL-IPI_Pat38	COL1A1--SPTBN1 Fusion	COL1A1	Imatinib	130	1693	37	370	19.015	20.406	11.327	18.171	21.375	16.435	0.835	6702.0
MEL-IPI_Pat38	COL1A1--SPTBN1 Fusion	SPTBN1	Imatinib	143	1680	34	373	15.198	16.421	9.635	18.466	21.731	16.427	0.043	7669.0
MEL-IPI_Pat38	COL1A1--SPTBN1 Fusion	COL1A1 Fusions	Imatinib	1	1822	0	407				18.312	21.287	16.03	nan	
MEL-IPI_Pat38	COL1A1--SPTBN1 Fusion	SPTBN1 Fusions	Imatinib	2	1821	0	407				18.312	21.287	16.03	nan	
MEL-IPI_Pat38	COL1A1--SPTBN1 Fusion	COL1A1--SPTBN1	Imatinib	0	1823	0	407				18.312	21.287	16.03	nan	
MEL-IPI_Pat38	ERCC2 p.V242I (Missense)	ERCC2	Cisplatin	104	1719	58	710	23.13	106.007	175.772	24.23	157.568	402.409	0.826	20233.0
MEL-IPI_Pat38	ERCC2 p.V242I (Missense)	ERCC2 Somatic Variant	Cisplatin	46	1777	28	740	22.081	91.258	172.512	24.724	156.035	395.847	0.749	10728.5
MEL-IPI_Pat38	ERCC2 p.V242I (Missense)	ERCC2 Somatic Variant Missense	Cisplatin	41	1782	25	743	22.908	75.415	143.127	24.55	156.307	395.5	0.571	9906.5
MEL-IPI_Pat38	ERCC2 p.V242I (Missense)	ERCC2 Somatic Variant Missense p.V242I	Cisplatin	1	1822	1	767	23.351	23.351		23.909	153.844	390.315	0.989	387.0
MEL-IPI_Pat38	ARAF p.L531F (Missense)	ARAF	Sorafenib	82	1741	46	711	10.952	41.88	85.526	11.509	36.973	108.332	0.593	15585.0
MEL-IPI_Pat38	ARAF p.L531F (Missense)	ARAF Somatic Variant	Sorafenib	34	1789	21	736	8.67	19.324	22.063	11.518	37.783	108.459	0.544	8328.5
MEL-IPI_Pat38	ARAF p.L531F (Missense)	ARAF Somatic Variant Missense	Sorafenib	28	1795	17	740	8.67	18.517	21.874	11.518	37.702	108.183	0.466	6940.5
MEL-IPI_Pat38	ARAF p.L531F (Missense)	ARAF Somatic Variant Missense p.L531F	Sorafenib	0	1823	0	757				11.486	37.271	107.045	nan	
MEL-IPI_Pat38	PTEN  (Splice Site)	PTEN	AZD8186	293	1530	151	601	17.17	35.635	49.53	28.168	59.533	106.383	1.966e-05	55562.5
MEL-IPI_Pat38	PTEN  (Splice Site)	PTEN Somatic Variant	AZD8186	179	1644	89	663	15.371	33.287	47.438	27.261	57.613	102.704	5.416e-05	37272.0
MEL-IPI_Pat38	PTEN  (Splice Site)	PTEN Somatic Variant Splice Site	AZD8186	0	1823	0	752				24.508	54.734	98.1	nan	
MEL-IPI_Pat38	ATM p.G197E (Missense)	ATM	Olaparib	316	1507	175	587	95.832	178.542	282.047	70.533	159.236	333.831	0.026	45658.0
MEL-IPI_Pat38	ATM p.G197E (Missense)	ATM Somatic Variant	Olaparib	223	1600	116	646	93.804	156.246	195.042	73.428	165.003	340.577	0.202	34682.0
MEL-IPI_Pat38	ATM p.G197E (Missense)	ATM Somatic Variant Missense	Olaparib	158	1665	85	677	91.776	153.512	181.88	74.761	164.945	336.201	0.33	26907.0
MEL-IPI_Pat38	ATM p.G197E (Missense)	ATM Somatic Variant Missense p.G197E	Olaparib	0	1823	0	762				75.933	163.67	322.6	nan	
MEL-IPI_Pat38	ATM p.P2907S (Missense)	ATM	Olaparib	316	1507	175	587	95.832	178.542	282.047	70.533	159.236	333.831	0.026	45658.0
MEL-IPI_Pat38	ATM p.P2907S (Missense)	ATM Somatic Variant	Olaparib	223	1600	116	646	93.804	156.246	195.042	73.428	165.003	340.577	0.202	34682.0
MEL-IPI_Pat38	ATM p.P2907S (Missense)	ATM Somatic Variant Missense	Olaparib	158	1665	85	677	91.776	153.512	181.88	74.761	164.945	336.201	0.33	26907.0
MEL-IPI_Pat38	ATM p.P2907S (Missense)	ATM Somatic Variant Missense p.P2907S	Olaparib	0	1823	0	762				75.933	163.67	322.6	nan	
MEL-IPI_Pat38	BRCA1 p.A1369T (Missense)	BRCA1	Olaparib	158	1665	94	668	90.45	192.521	281.117	73.428	159.61	328.001	0.22	28944.0
MEL-IPI_Pat38	BRCA1 p.A1369T (Missense)	BRCA1 Somatic Variant	Olaparib	99	1724	57	705	121.094	214.27	319.401	74.675	159.579	322.735	0.083	17323.0
MEL-IPI_Pat38	BRCA1 p.A1369T (Missense)	BRCA1 Somatic Variant Missense	Olaparib	79	1744	50	712	128.869	234.74	335.719	73.842	158.679	321.312	0.027	14463.0
MEL-IPI_Pat38	BRCA1 p.A1369T (Missense)	BRCA1 Somatic Variant Missense p.A1369T	Olaparib	0	1823	0	762				75.933	163.67	322.6	nan	
MEL-IPI_Pat38	PIK3CA  (Splice Site)	PIK3CA	Alpelisib	290	1533	168	636	21.552	60.02	114.4	40.7	110.798	275.448	1.905e-06	66177.0
MEL-IPI_Pat38	PIK3CA  (Splice Site)	PIK3CA Somatic Variant	Alpelisib	161	1662	106	698	15.426	47.763	80.712	40.244	108.149	266.996	3.367e-08	49295.0
MEL-IPI_Pat38	PIK3CA  (Splice Site)	PIK3CA Somatic Variant Splice Site	Alpelisib	0	1823	0	804				32.558	100.187	251.29	nan	
MEL-IPI_Pat38	BARD1  (Splice Site)	BARD1	Olaparib	80	1743	46	716	95.795	174.51	231.0	74.41	162.973	327.719	0.161	14441.0
MEL-IPI_Pat38	BARD1  (Splice Site)	BARD1 Somatic Variant	Olaparib	57	1766	34	728	112.029	147.025	150.312	75.237	164.447	328.479	0.404	11329.0
MEL-IPI_Pat38	BARD1  (Splice Site)	BARD1 Somatic Variant Splice Site	Olaparib	0	1823	0	762				75.933	163.67	322.6	nan	
MEL-IPI_Pat38	CHEK1 p.G16E (Missense)	CHEK1	Olaparib	121	1702	69	693	102.103	190.58	335.198	72.821	160.99	321.445	0.042	20354.0
MEL-IPI_Pat38	CHEK1 p.G16E (Missense)	CHEK1 Somatic Variant	Olaparib	21	1802	11	751	182.893	219.868	237.343	75.198	162.847	323.726	0.11	2973.0
MEL-IPI_Pat38	CHEK1 p.G16E (Missense)	CHEK1 Somatic Variant Missense	Olaparib	18	1805	9	753	192.551	245.002	255.063	75.198	162.698	323.332	0.078	2231.0
MEL-IPI_Pat38	CHEK1 p.G16E (Missense)	CHEK1 Somatic Variant Missense p.G16E	Olaparib	0	1823	0	762				75.933	163.67	322.6	nan	
MEL-IPI_Pat38	BRIP1 p.T166I (Missense)	BRIP1	Olaparib	137	1686	81	681	97.835	201.839	284.91	72.821	159.13	326.685	0.049	23899.0
MEL-IPI_Pat38	BRIP1 p.T166I (Missense)	BRIP1 Somatic Variant	Olaparib	85	1738	52	710	76.17	125.105	143.043	75.933	166.494	331.835	0.834	18781.0
MEL-IPI_Pat38	BRIP1 p.T166I (Missense)	BRIP1 Somatic Variant Missense	Olaparib	69	1754	41	721	75.198	126.748	151.095	76.59	165.769	329.615	0.699	15311.0
MEL-IPI_Pat38	BRIP1 p.T166I (Missense)	BRIP1 Somatic Variant Missense p.T166I	Olaparib	0	1823	0	762				75.933	163.67	322.6	nan	
MEL-IPI_Pat38	ERRFI1 p.K42K (Splice Site)	ERRFI1	Erlotinib	114	1709	53	699	17.206	39.109	52.781	13.187	23.308	32.804	0.13	16215.5
MEL-IPI_Pat38	ERRFI1 p.K42K (Splice Site)	ERRFI1 Somatic Variant	Erlotinib	30	1793	13	739	10.176	16.755	18.386	13.448	24.556	34.988	0.303	5603.5
MEL-IPI_Pat38	ERRFI1 p.K42K (Splice Site)	ERRFI1 Somatic Variant Splice Site	Erlotinib	1	1822	0	752				13.41	24.421	34.777	nan	
MEL-IPI_Pat38	ERRFI1 p.K42K (Splice Site)	ERRFI1 Somatic Variant Splice Site p.K42K	Erlotinib	0	1823	0	752				13.41	24.421	34.777	nan	
MEL-IPI_Pat38	JAK3 p.R451* (Nonsense)	JAK3	Ruxolitinib	92	1731	58	670	125.284	170.224	156.01	126.74	195.163	267.172	0.952	19523.0
MEL-IPI_Pat38	JAK3 p.R451* (Nonsense)	JAK3 Somatic Variant	Ruxolitinib	67	1756	46	682	112.944	168.732	161.687	126.85	194.825	265.403	0.787	16059.0
MEL-IPI_Pat38	JAK3 p.R451* (Nonsense)	JAK3 Somatic Variant Nonsense	Ruxolitinib	1	1822	0	728				126.74	193.176	260.077	nan	
MEL-IPI_Pat38	JAK3 p.R451* (Nonsense)	JAK3 Somatic Variant Nonsense p.R451*	Ruxolitinib	0	1823	0	728				126.74	193.176	260.077	nan	
